SLAS2018 Restaurant Guide: San Diego

SLAS2018 is back in San Diego at the San Diego Convention Center February 3–7, 2018. If you’re heading to SLAS for the first time, I recommend checking out their website to learn all that the conference has to offer. Outside of amazing presenters and exhibitors, you will find a variety of networking opportunities and educational…

Read more

Anti-SIRPα Antibodies: A Promising Avenue for Immunotherapy

Conventional cancer therapies such as chemotherapy and radiation have a significant downfall: while targeting cancerous tumors, they also damage healthy cells which can lead to undesirable patient side-effects. Despite high expectations at the onset, treatments using monoclonal antibodies have historically faced limitations. While attempting to discover why monoclonal antibodies were not performing as expected, researchers…

Read more

Thank You for a Great 2017!

It’s hard to believe 2017 is coming to a close in just a few short days. What a year it has been! There have been many groundbreaking immunotherapy innovations this year. From the first-ever FDA-approved CAR-T cell therapy to the federal PACT initiative investing $215 million in immunotherapy research to countless other advancements, it’s incredible…

Read more

New Evidence of Oxidative Burst in Neutrophils

Neutrophils are known for the oxidative burst released during phagocytosis, which demonstrates the intracellular killing mechanism that is key to the function of the immune system. Until now, we were not able to demonstrate this oxidative burst in our cryopreserved neutrophil products even though we knew they were capable of phagocytosis. Improved Isolation Methods Our…

Read more

Highlights from SITC 2017

This was out first time at the Society for Immunotherapy of Cancer’s annual event, and we weren’t disappointed! For those of you unable to make it to SITC this year, enjoy our take on the event highlights. To all those we met, see you next year! 1. Tumors Acquire Resistance to Treatment with Checkpoint Inhibitors…

Read more

Vote for the Next Astarte Immune Cell Product!

Our new product pipeline has always been driven by customer demand. Now we’re giving you the chance to recommend our next new product! Is there an immune cell product that would make your job easier? One that would vastly improve or expand your research capabilities? Something that you’ve never been able to find? Let us…

Read more

Ask A Scientist: Is There an Alternative Measure of Autoimmune Disease Activity?

Many autoimmune diseases are characterized by the presence of antibodies to normal proteins. For example, in rheumatoid arthritis (RA), it’s typical to see antibodies to citrullinated peptides. In Systemic lupus erythematosus (SLE), antibodies to double-stranded DNA and other nuclear proteins are hallmarks of the disease. Physicians use these different antibody reactivity patterns to distinguish autoimmune…

Read more
man looking through a microscope

How Biomaterials Are Changing Cancer Treatment

There are hundreds, if not thousands, of types and subtypes of cancer in the world today. Although treatments exist for many of these cancer types, no treatment is one-hundred percent effective yet. Researchers and physicians are constantly in pursuit of new treatment options to better eradicate cancer cells in the body. One of the latest…

Read more